Wakefield Asset Management Lllp Organogenesis Holdings Inc. Transaction History

Wakefield Asset Management Lllp

  • $294 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 02, 2022
SELL
$6.47 - $9.57 $550,364 - $814,062
-85,064 Closed
0 $0
Q4 2021

Feb 01, 2022
BUY
$9.02 - $13.5 $297,064 - $444,609
32,934 Added 63.18%
85,064 $786,000
Q3 2021

Nov 12, 2021
SELL
$13.71 - $17.18 $15,026 - $18,829
-1,096 Reduced 2.06%
52,130 $742,000
Q2 2021

Aug 10, 2021
BUY
$14.92 - $23.23 $794,131 - $1.24 Million
53,226 New
53,226 $885,000

Others Institutions Holding ORGO

# of Institutions
117
Shares Held
63.2M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $505M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Wakefield Asset Management Lllp Portfolio

Follow Wakefield Asset Management Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wakefield Asset Management Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Wakefield Asset Management Lllp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email